What Is the Risk of Reactivation in Patients with Resolved and Past HBV Infection During Immunosuppressive Therapy If HBV-DNA Negative before Treatment?

Background: Reactivation of Hepatitis B (HBVr) related to immunosuppressive drug therapy (ISDT) in patients with resolved and past infection is a challenging entity. The number of prospective long-term studies is limited. Methods: Two groups of patients with resolved and past HBV infection were an...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Salih Tokmak, Yüksel Gümürdülü, Didem A. Taş, İbrahim O. Kara, Ahmet B. Güzel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Turkish Society of Gastroenterology 2021-03-01
Serie:	The Turkish Journal of Gastroenterology
Soggetti:	Hepatitis B antigens rituximab prophylaxis immunosuppressants antineoplastic agents
Accesso online:	https://turkjgastroenterol.org/index.php/tjg/article/view/3716
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!